We enthusiastically welcome Scott and colleagues' article highlighting the real need to deprescribe in older patients;1 however, we would like to emphasise the role of validated tools and medication management reviews in deprescribing.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
- 1. Scott IA, Anderson K, Freeman CR, Stowasser D. First do no harm: a real need to deprescibe in older patients. Med J Aust 2014; 201: 390-392. <MJA full text>
- 2. Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012; 28: 237-253.
- 3. Nishtala PS, Hilmer SN, McLachlan AJ, et al. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging 2009; 26: 677-686.
- 4. Castelino RL, Hilmer SN, Bajorek BV, et al. Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs Aging 2010; 27: 135-148.
- 5. Carter SR, Moles R, White L, Chen TF. Exploring patients' motivation to participate in Australia's Home Medicines Review Program. Int J Clin Pharm 2012; 34: 658-666.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.